Pfizer Limited reported earnings results for the third quarter and nine months ended December 31, 2023. For the third quarter, the company reported sales was INR 5,399.7 million compared to INR 6,217.5 million a year ago. Revenue was INR 5,758.2 million compared to INR 6,491.6 million a year ago. Net income was INR 1,299.8 million compared to INR 1,506.6 million a year ago. Basic earnings per share from continuing operations was INR 28.42 compared to INR 32.93 a year ago. Diluted earnings per share from continuing operations was INR 28.42 compared to INR 32.93 a year ago.
For the nine months, sales was INR 16,465.4 million compared to INR 18,521.2 million a year ago. Revenue was INR 17,519.2 million compared to INR 19,217.9 million a year ago. Net income was INR 3,724.7 million compared to INR 4,942.8 million a year ago. Basic earnings per share from continuing operations was INR 81.42 compared to INR 108.04 a year ago. Diluted earnings per share from continuing operations was INR 81.42 compared to INR 108.04 a year ago.